Advancing cellular immunotherapy to treat cancer Pioneering stem cell research & therapy

Turning gamma delta (γδ) T cells

and natural killer (NK) cells into

“off-the-shelf” immunotherapeutics 

for various cancers.

Note: The background image shows iPSC-derived NK cells and the video shows iPSC-derived γδ T cells killing colorectal cancer cells.


Follow us for more updates